Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NDAC meeting date canceled

This article was originally published in The Tan Sheet

Executive Summary

Meeting of FDA's Nonprescription Drugs Advisory Committee that was to be held July 27 jointly with the Drug Abuse Advisory Committee has been canceled. Past joint meetings of the two committees have focused on smoking cessation products ("The Tan Sheet" May 26, p. 11). NDAC is scheduled to proceed with its July 28 and 29 meetings to discuss, respectively, labeling of vaginal antifungal products and healthcare antiseptic testing requirements...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088510

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel